Adaption and Responses: Myocardial Innervations and Neural Control

Muscle: Fundamental Biology and Mechanisms of Disease

Volumn 1-2, Issue , 2012, Pages 275-284

  Herring, Neil ^a   Paterson, David J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890390472     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381510-1.00020-X     Document Type: Chapter

References (77)

1. Krogh A., Lindhard J. The regulation of respiration and circulation during the initial stages of muscular work. J Physiol 1913, 47:112-136.
2. Goodwin G.M., McCloskey D.I., Mitchell J.H. Cardiovascular and respiratory responses to changes in central command during isometric exercise at constant muscle tension. J Physiol 1972, 226:173-190.
3. Mitchell J.H. J.B. Wolffe memorial lecture. Neural control of the circulation during exercise. Med Sci Sports Ex 1990, 22:141-154.
4. Thornton J.M., Guz A., Murphy K., Griffith A.R., Pedersen D.L., Kardos A., et al. Identification of higher brain centres that may encode the cardiorespiratory response to exercise in humans. J Physiol 2001, 533:823-836.
5. Williamson J.W., Fadel P.J., Mitchell J.H. New insights into central cardiovascular control during exercise in humans: a central command update. Exp Physiol 2006, 91:51-58.
6. Williamson J.W., McColl R., Mathews D., Ginsburg M., Mitchell J.H. Activation of the insular cortex is affected by the intensity of exercise. J App Physiol 1999, 87:1213-1219.
7. Green A.L., Paterson D.J. Identification of neurocircuitry controlling cardiovascular function in humans using functional neurosurgery: implications for exercise control. Exp Physiol 2008, 93:1022-1028.
8. Green A.L., Wang S., Purvis S., Owen S.L., Bain P.G., Stein J.F., et al. Identifying cardiorespiratory neurocircuitry involved in central command during exercise in humans. J Physiol 2007, 578:605-612.
9. Green A.L., Wang S., Owen S.L., Xie K., Liu X., Paterson D.J., et al. Deep brain stimulation can regulate arterial blood pressure in awake humans. Neuroreport 2005, 16:1741-1745.
10. Thornton J.M., Aziz T., Schlugman D., Paterson D.J. Electrical stimulation of the midbrain increases heart rate and arterial blood pressure in awake humans. J Physiol 2002, 539:615-621.
11. Alam M., Smirk F.H. Observations in man upon a blood pressure raising reflex arising from the voluntary muscles. J Physiol 1937, 89:372-383.
12. Coote J.H., Hilton S.M., Perez-Gonzalez J.F. The reflex nature of the pressor response to muscular exercise. J Physiol 1971, 215:789-804.
13. McCloskey D.I., Mitchell J.H. Reflex cardiovascular and respiratory responses originating in exercising muscle. J Physiol 1972, 224:173-186.
14. Basnayake S.D., Hyam J.A., Pereira E.A., Schweder P.M., Brittain J.S., Aziz T.Z., et al. Identifying cardiovascular neurocircuitry involved in the exercise pressor reflex in humans using functional neurosurgery. J App Physiol 2011, 110(4):881-891.
15. Armour J.A. Potential clinical relevance of the "little brain" on the mammalian heart. Exp Physiol 2008, 93:165-176.
16. Pauza D.H., Skripka V., Pauziene N., Stropus R. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec 2000, 259:353-382.
17. Edwards F.R., Hirst G.D., Klemm M.F., Steele P.A. Different types of ganglion cell in the cardiac plexus of guinea-pigs. J Physiol 1995, 486(Pt 2):453-471.
18. Parsons S.M., Prior C., Marshall I.G. Acetylcholine transport, storage, and release. Int Rev Neurobiol 1993, 35:279-390.
19. Steele P.A., Choate J.K. Innervation of the pacemaker in guinea-pig sinoatrial node. J Auton Nerv Syst 1994, 47:177-187.
20. Beaulieu P., Lambert C. Peptidic regulation of heart rate and interactions with the autonomic nervous system. Cardiovasc Res 1998, 37:578-585.
21. Paton J.F., Kasparov S., Paterson D.J. Nitric oxide and autonomic control of heart rate: a question of specificity. Trends Neurosci 2002, 25:626-631.
22. Herring N., Paterson D.J. Neuromodulators of peripheral cardiac sympatho-vagal balance. Exp Physiol 2009, 94:46-53.
23. Iverson L. Letter: High affinity uptake of neurotransmitter amino acids. Nature 1975, 253:481-482.
24. Kummer W. Galanin- and neuropeptide Y-like immunoreactivities coexist in paravertebral sympathetic neurones of the cat. Neurosci Lett 1987, 78:127-131.
25. Warner M.R., Levy M.N. Sinus and atrioventricular nodal distribution of sympathetic fibers that contain neuropeptide Y. Circ Res 1990, 67:713-721.
26. Burnstock G. Autonomic neurotransmission: 60 years since Sir Henry Dale. Annu Rev Pharmacol Toxicol 2009, 49:1-30.
27. Potter E.K., Smith-White M.A. Galanin modulates cholinergic neurotransmission in the heart. Neuropeptides 2005, 39:345-348.
28. Warner M.R., Levy M.N. Neuropeptide Y as a putative modulator of the vagal effects on heart rate. Circ Res 1989, 64:882-889.
29. Schwertfeger E., Klein T., Vonend O., Oberhauser V., Stegbauer J., Rump L.C. Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors. Naunyn Schmiedebergs Arch Pharmacol 2004, 369:455-461.
30. Matko I., Feher E., Vizi E.S. Receptor mediated presynaptic modulation of the release of noradrenaline in human papillary muscle. Cardiovasc Res 1994, 28:700-704.
31. Malliani A., Schwartz P.J., Zanchetti A. A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol 1969, 217:703-709.
32. Malliani A., Pagani M., Bergamaschi M. Positive feedback sympathetic reflexes and hypertension. Am J Cardiol 1979, 44:860-865.
33. Irisawa H., Brown H.F., Giles W. Cardiac pacemaking in the sinoatrial node. Physiol Rev 1993, 73:197-227.
34. + channels in isolated pacemaker cells of the mammalian heart. Nature 1983, 303:250-253.
35. Rudolph U., Spicher K., Birnbaumer L. Adenylyl cyclase inhibition and altered G protein subunit expression and ADP-ribosylation patterns in tissues and cells from Gi2 alpha-/-mice. Proc Nat Acad Sci USA 1996, 93:3209-3214.
36. DiFrancesco D., Tortora P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 1991, 351:145-147.
37. DiFrancesco D., Tromba C. Muscarinic control of the hyperpolarization-activated current (If) in rabbit sino-atrial node myocytes. J Physiol 1988, 405:493-510.
38. DiFrancesco D., Tromba C. Inhibition of the hyperpolarization-activated current (If) induced by acetylcholine in rabbit sino-atrial node myocytes. J Physiol 1988, 405:477-491.
39. 2+ exchange current in isolated toad pacemaker cells. J Physiol 1998, 508(Pt 1):153-166.
40. 2+ oscillations drive sinoatrial nodal cell pacemaker function to make the heart tick. Ann NY Acad Sci 2005, 1047:138-156.
41. 2+ cycling with surface membrane channels. J Mol Cell Cardiol 2009, 47:456-474.
42. Hagiwara N., Irisawa H., Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol 1988, 395:233-253.
43. Mitsuiye T., Shinagawa Y., Noma A. Sustained inward current during pacemaker depolarization in mammalian sinoatrial node cells. Circ Res 2000, 87:88-91.
44. Lei M., Brown H.F., Terrar D.A. Modulation of delayed rectifier potassium current, iK, by isoprenaline in rabbit isolated pacemaker cells. Exp Physiol 2000, 85:27-35.
45. Kranias E.G., Solaro R.J. Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart. Nature 1982, 298:182-184.
46. Rigg L., Heath B.M., Cui Y., Terrar D.A. Localisation and functional significance of ryanodine receptors during beta-adrenoceptor stimulation in the guinea-pig sino-atrial node. Cardiov Res 2000, 48:254-264.
47. Han X., Shimoni Y., Giles W.R. An obligatory role for nitric oxide in autonomic control of mammalian heart rate. J Physiol 1994, 476:309-314.
48. Ashley E.A., Sears C.E., Bryant S.M., Watkins H.C., Casadei B. Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes. Circulation 2002, 105:3011-3016.
49. Musialek P., Lei M., Brown H.F., Paterson D.J., Casadei B. Nitric oxide can increase heart rate by stimulating the hyperpolarization-activated inward current, I(f). Circ Res 1997, 81:60-68.
50. Sears C.E., Choate J.K., Paterson D.J. Inhibition of nitric oxide synthase slows heart rate recovery from cholinergic activation. J Appl Physiol 1998, 84:1596-1603.
51. Balligand J.L. Regulation of cardiac beta-adrenergic response by nitric oxide. Cardiovasc Res 1999, 43:607-620.
52. Herring N., Danson E.J., Paterson D.J. Cholinergic control of heart rate by nitric oxide is site specific. News Physiol Sci 2002, 17:202-206.
53. Martin S.R., Emanuel K., Sears C.E., Zhang Y.H., Casadei B. Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation. Cardiovasc Res 2006, 70:97-106.
54. Seddon M., Shah A.M., Casadei B. Cardiomyocytes as effectors of nitric oxide signaling. Cardiov Res 2007, 75:315-326.
55. + channel via cyclic AMP-dependent protein kinase in atrial cells. Circ Res 1990, 67:1292-1298.
56. Mizuno M., Kamiya A., Kawada T., Miyamoto T., Shimizu S., Shishido T., et al. Accentuated antagonism in vagal heart rate control mediated through muscarinic potassium channels. J Physiol Sci 2008, 58:381-388.
57. Opie L.H., Clusin W.T. Cellular mechanism for ischemic ventricular arrhythmias. Annu Rev Med 1990, 41:231-238.
58. Lubbe W.F., Podzuweit T., Opie L.H. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors. J Am Coll Cardiol 1992, 19:1622-1633.
59. Kleiger R.E., Miller J.P., Bigger J.T., Moss A.J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987, 59:256-262.
60. La Rovere M.T., Bigger J.T., Marcus F.I., Mortara A., Schwartz P.J. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic tone and reflexes after myocardial infarction) Investigators. Lancet 1998, 351:478-484.
61. Cohn J.N., Levine T.B., Olivari M.T., Garberg V., Lura D., Francis G.S., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984, 311:819-823.
62. Nolan J., Batin P.D., Andrews R., Lindsay S.J., Brooksby P., Mullen M., et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998, 98:1510-1516.
63. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009, 54:690-697.
64. Schlaich M.P., Kaye D.M., Lambert E., Sommerville M., Socratous F., Esler M.D. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003, 108:560-565.
65. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. New Engl J Med 1990, 322:1561-1566.
66. Ng G.A., Brack K.E., Patel V.H., Coote J.H. Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart. Cardiovasc Res 2007, 73:750-760.
67. Danson E.J., Paterson D.J. Enhanced neuronal nitric oxide synthase expression is central to cardiac vagal phenotype in exercise-trained mice. J Physiol 2003, 546:225-232.
68. Cole C.R., Blackstone E.H., Pashkow F.J., Snader C.E., Lauer M.S. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 1999, 341:1351-1357.
69. Langewitz W., Ruddel H., Schachinger H. Reduced parasympathetic cardiac control in patients with hypertension at rest and under mental stress. Am Heart J 1994, 127:122-128.
70. First International Study of Infarct Survival Collaborative Group Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986, 2:57-66.
71. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) A randomised trial. Lancet 1999, 353:9-13.
72. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987, 316:1429-1435.
73. Pfeffer M.A., Braunwald E., Moye L.A., Basta L., Brown E.J., Cuddy T.E., et al. The SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992, 327:669-677.
74. Schwartz P.J. Vagal stimulation for heart diseases: from animals to men. An example of translational cardiology. Circ J 2010, 75:20-27.
75. Triposkiadis F., Karayannis G., Giamouzis G., Skoularigis J., Louridas G., Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009, 54:1747-1762.
76. McDermott B.J., Bell D. NPY and cardiac diseases. Curr Top Med Chem 2007, 7:1692-1703.
77. Paton J.F., Wang S., Polson J.W., Kasparov S. Signaling across the blood brain barrier by angiotensin II: novel implications for neurogenic hypertension. J Mol Med 2008, 86:705-710.